MONDAY, Jan. 10, 2022 (HealthDay News) — Researchers say they’ve uncovered a clue to why the Omicron variant spreads COVID-19 so much more rapidly than its predecessors. People who are infected but have no symptoms are still far more likely to infect others than they would have been with earlierContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — For people newly diagnosed with advanced melanoma, a combination of two immunotherapy drugs can double the amount of time their cancer remains progression-free, a clinical trial has found. The treatment combines two drugs known as immune checkpoint inhibitors. One, called nivolumab (Opdivo), isContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — Vaccination is still the best way to protect someone from COVID-19, but new research suggests that immune system activation of T-cells by common colds may offer some cross-protection. The study might also provide a blueprint for a second-generation, universal vaccine that could preventContinue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) — The Supreme Court began to hear oral arguments on Friday as it weighs whether the Biden administration can enforce vaccine mandates for large companies. The justices are also hearing arguments on a separate vaccine mandate for most health care workers. The court’s decisionContinue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) — A review of cases from 465 U.S. hospitals underscores the protection provided by COVID-19 vaccines. The new review — by researchers at the U.S. National Institutes of Health — found that vaccinated adults who got breakthrough infections rarely got severely ill. Respiratory failure,Continue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) — Citing the rapid spread of the Omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a booster shot from six months down to five. “TheContinue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading
FRIDAY, JAN. 6, 2022 (HealthDay News) — A fourth COVID shot may be needed for most people by next fall because of what will likely be waning immunity, Moderna CEO Stephane Bancel said Thursday. While the booster that millions of Americans received this past fall should hold strong through thisContinue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) — Although some U.S. states put up big amounts of cash to influence residents to get their COVID-19 vaccinations, it didn’t appear to make much any difference in immunization rates. Investigators who found that to be true in an earlier study in Ohio lookedContinue Reading
THURSDAY, Jan. 6, 2022 (HealthDay News) — The Abbott BinaxNOW and Quidel QuickVue — two widely used rapid at-home COVID tests — may sometimes fail to spot evidence of the Omicron variant in the first days after infection, even when people are carrying substantial levels of the virus, preliminary researchContinue Reading